Aubrai, a decentralized science AI, has launched on the Base platform to tackle funding challenges in scientific research. The project was developed with the support of VitaDAO and Bio Protocol.
Launch of Aubrai on Base
Aubrai was launched on the Base network to address the complexities of funding scientific research. This initiative is particularly focused on overcoming the 'valley of death' in longevity studies.
Key Players Involved
Key participants in the project include Dr. **Aubrey de Grey**, a prominent biomedical gerontologist, as well as VitaDAO and Bio Protocol. Aubrai operates as a decentralized scientific agent that integrates unpublished data and aids in experimental design.
Impact on Science Research Market
The launch of Aubrai has the potential to alter funding approaches in the fields of longevity and biotechnology. The introduction of the AUBRAI token and its distribution strategy could significantly impact funding mechanisms for scientific research. Some experts anticipate increased interest from institutional investors.
The launch of Aubrai highlights the growing interest in decentralized solutions for science funding and may represent an important step towards improving financing for long-term research.
